| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 05/18/2006 | CA2586135A1 Compositions and processes for preparing 13-deoxy-anthracyclines |
| 05/18/2006 | CA2586122A1 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| 05/17/2006 | EP1656388A2 Process for preparing maltitol enriched products |
| 05/17/2006 | CN1256342C Acetamido glucose devicative of indomethacin and its synthetic method and use |
| 05/17/2006 | CN1256341C Synthesis of rhodiola glycoside compound |
| 05/16/2006 | US7045665 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 05/16/2006 | US7045506 stability; discoloration inhibition, odorless; applying to hair, skin |
| 05/16/2006 | US7045494 Adjustment of pH; purification using ion exchange resin; controlling viscosity and temperature |
| 05/11/2006 | WO2006048165A1 Mixtures of quaternary and non-ionic surfactants |
| 05/11/2006 | US20060100423 Process for the preparation and separation of arabinose and xylose from a mixture of saccharides |
| 05/11/2006 | US20060100421 Compositions and processes for preparing 13-deoxy-anthracyclines |
| 05/11/2006 | US20060100163 Oligosaccharides linked by amide, imine,ether, ester, carbonate, carbamate, urea, thioester bond to active agent produce hydrophilicity; easily produced with homogeneity, predictable, desirable pharmacokinetic profile, enhanced biocompatibility |
| 05/11/2006 | US20060099165 Fatty acid esters of ethoxylated alkylglucosides |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1654269A1 Novel compounds |
| 05/10/2006 | EP1654268A2 Lincomycin derivatives possessing antibacterial activity |
| 05/10/2006 | EP1334109B1 Improved synthesis of purine locked nucleic acid analogues |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1210355B1 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 05/10/2006 | EP0957161B1 Method for activating human antigen presenting cells, activated human antigen presenting cells, and use of the same |
| 05/10/2006 | CN1768759A Nkt cell-activating agents containing alpha-glycosylceramides |
| 05/04/2006 | WO2006046674A1 Preventive and remedy for hepatitis c virus infection |
| 05/04/2006 | WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 05/03/2006 | EP1284102B1 Syrup-containing compositions and process for producing the same |
| 05/03/2006 | CN1768073A Oligosaccharide derivative |
| 05/03/2006 | CN1768072A Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 04/27/2006 | WO2006043705A1 Type ii cubic liquid crystal composition |
| 04/27/2006 | WO2005092907A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| 04/27/2006 | US20060089330 Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans |
| 04/27/2006 | US20060088613 Simmondsin for use as angiogenesis inhibitor |
| 04/27/2006 | US20060088491 Novel polyol-glycoside compositions for the skin |
| 04/27/2006 | CA2584560A1 Type ii cubic liquid crystal composition |
| 04/26/2006 | EP1649861A2 Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/26/2006 | EP1649037A2 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/26/2006 | EP0841949B1 Use of saccharide conjugates |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/20/2006 | WO2006017726A3 Polysulfated glycosides and salts thereof |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/19/2006 | EP1647277A1 Glycoside-containing liposome |
| 04/19/2006 | EP1572708B1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | CN1759665A Method for preparing polygonin through tissue culture and inducement of hairy roots of giant knotweed |
| 04/18/2006 | US7030156 Devices and methods for eliminating termite colonies |
| 04/18/2006 | US7030093 Antibiotic coating for porous bodies and method for its production as well as its use |
| 04/18/2006 | US7029886 Detecting microorganisms using enzyme substrate |
| 04/18/2006 | US7029671 Method for activating human antigen-presenting cells, activated human antigen-presenting cells, and use thereof |
| 04/18/2006 | CA2247513C Camptothecin derivatives and the use thereof as antitumor agents |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/18/2006 | CA2148943C Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates |
| 04/13/2006 | WO2006038440A1 Process for producing glycoside derivative |
| 04/13/2006 | WO2006037185A1 Novel sulfenamides and sulfenamide oxides |
| 04/13/2006 | WO2005063785A3 Glucopyranosyloxy-substituted aromates, medicaments containing said compounds, the use thereof, and methods for producing the same |
| 04/13/2006 | US20060079466 Rapamycin carbohydrate derivatives |
| 04/13/2006 | US20060079465 isolated from the Caenorhabditis elegance related to suppress of aging and stress |
| 04/13/2006 | US20060078980 Production of polyketides and other natural products |
| 04/13/2006 | CA2579678A1 Selective inhibitors |
| 04/12/2006 | EP1644393A2 Novel lincomycin derivatives possessing antimicrobial activity |
| 04/12/2006 | EP1644392A1 Rapamycin carbohydrate derivatives |
| 04/12/2006 | EP1644391A2 Steroid modified solatrioses |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1268505B1 Solid phase synthesis method and reagent |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1250235C Anti-protozoon saponins |
| 04/11/2006 | US7025985 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 04/06/2006 | WO2005100373A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| 04/06/2006 | US20060074235 Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 04/06/2006 | US20060074031 D-pyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/06/2006 | US20060073222 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 04/06/2006 | US20060073122 Method for activating human antigen presenting cells, activated human antigen - presenting cells, and use thereof |
| 04/06/2006 | DE4414863B4 Verfahren zur Herstellung lagerstabiler Sulfosuccinate und Sulfosuccinamate A process for producing storable Sulfosuccinate and sulfosuccinamates |
| 04/05/2006 | CN1249071C Process for synthesis of optically active anthracyclines |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/05/2006 | CN1248992C Preparation of oligomer and monomer from tannin by catalytic hydrogen degradation |
| 04/04/2006 | US7022839 Heterodimeric conjugates of neomycin-chloramphenicol having an enhanced specificity against RNA targets and its preparation |
| 04/04/2006 | US7022667 Mycobacterium; grampositive bacteria bactericides, antibiotics |
| 04/04/2006 | US7022661 for use as emulsifiers, hair conditioners and fabric softeners; pollution control |
| 04/04/2006 | CA2231199C 1,2 chemiluminescent dioxetanes of improved performance |
| 03/30/2006 | CA2581673A1 C-aryl glucoside sglt2 inhibitors and method |
| 03/29/2006 | EP1640379A1 Method of synthesizing sugar chain |
| 03/29/2006 | EP1638509A2 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 03/29/2006 | EP1572707B1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 03/29/2006 | EP1062840B1 Apparatus and method for a custom soft-solid hearing aid |
| 03/29/2006 | CN1247606C Two (Z)-4-hydroxycinnamic acid glycosides and their application |
| 03/29/2006 | CN1247605C Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 03/23/2006 | WO2006029837A1 Reacting amino alcohols with acidic, organic substrates according to a mitsunobu-reaction |
| 03/23/2006 | US20060063726 Crystallization in ethanol, propanol, or isopropanol solvent; acidification, evaporation; anticarcinogenic agents |
| 03/22/2006 | EP1636586A2 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | CN1751057A Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses |
| 03/22/2006 | CN1246325C Preparation method of gadol effective component extract |
| 03/21/2006 | US7015202 Adjust migration of monocytes, lymphocytes or interleukins; controllinginfections |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/16/2006 | WO2006028229A1 Benzonaphthaceneglycoside derivative and use thereof |
| 03/16/2006 | WO2006027987A1 Preventive or therapeutic agent for urination disorder |
| 03/16/2006 | WO2006027784A2 Bifunctional antibiotics for targeting rrna and resistance causing enzymes and for inhibition of anthrax lethal factor |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |